Wikipedia -WSS

Wikipedia

author：hotspot 2025-10-02 10:45:18 - browse：4

Moderna's mResvia vaccine — The FDA has approved Moderna’s RSV vaccine for older adults. Moderna

The Food and Drug Administration on Friday approved Moderna’s vaccine to protect older adults against respiratory syncytial virus, or RSV, making this the company’s second licensed product.

The Moderna RSV vaccine, which will be marketed under the name mResvia, was approved for adults 60 and older. It is made using the same messenger RNA platform as Moderna’s other licensed product, its Covid-19 vaccine Spikevax.

“The FDA approval of our second product, mResvia, builds on the strength and versatility of our mRNA platform,” Moderna CEO Stéphane Bancel said in a statement.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Traditional Chinese medicine benefits explored in new JAMA study

focus

WSS

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Reports of telehealth's death have been greatly exaggerated

Questions and answers about ramping up H5N1 bird flu vaccine

Readout Newsletter: New research from Sanofi, Regeneron, etc.

UnitedHealth argues against case alleging wrongful AI care denials

CDC recommends rationing of RSV shot due to shortages

explore

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

At least 13 dead in Texas as scorching temps continue

Senate panel to vote on hospitals, PBMs, prisoner care

Alkermes shareholders re

FDA has safety concerns on CRISPR

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Investigation reveals sickle cell patients pressured into sterilizations

Trump demands the U.S. pay no more for drugs than other countries … again

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Affirmative action in medical school literally saved lives

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

hotspot

Liver decline slowed by off

Medtronic CEO on promising devices for diabetes, hypertension

Telehealth options flood the market as retailers push virtual care

The FDA weighs the risks of candy

Reports of telehealth's death have been greatly exaggerated

Reports of telehealth's death have been greatly exaggerated

focus

hotspot

hotspot

hotspot